[Observation of the long-term clinical efficacy of "Fuyang Guben" acupuncture-moxibustion therapy on perennial allergic rhinitis and its effects on the total IgE and IL-4 in the serum].

Autor:	Wu FH; Department of Otolaryngology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031,China., Zha BX; Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031,China., Zhang TT; Department of Otolaryngology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031,China., Chen ZH; Department of Otolaryngology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031,China., Zhao H; Acupuncture and Moxibustion Hospital, China Academy of Chinese Medical Sciences, Beijing 100700., Liu G; Department of Otolaryngology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031,China.
Jazyk:	čínština
Zdroj:	Zhen ci yan jiu = Acupuncture research [Zhen Ci Yan Jiu] 2023 Jun 25; Vol. 48 (6), pp. 600-5.
DOI:	10.13702/j.1000-0607.20221293
Abstrakt:	Objective: To investigate the long-term clinical efficacy and safety of "Fuyang Guben" (supporting yang and consolidating root) acupuncture-moxibustion therapy on perennial allergic rhinitis (PAR), and to explore its functioning mechanism. Methods: The patients with PAR were randomly divided into acupuncture + western medicine group ( n =30) and western medicine group ( n =30). In the western medicine group, fluticasone propionate nasal spray was administered, one spray in each nostril in one treatment, once a day, for 6 weeks. On the basis of the western medicine group, fuyangguben acupuncture-moxibustion therapy was supplemented. Acupuncture was applied to Shangxing (GV23), Yintang (GV24+), and bilateral Yingxiang (LI20), Shangyingxiang (EX-HN8), Sibai (ST2), Hegu (LI4) and Chize (LU5); warm needling was applied at Dazhui (GV14). The patients of this group received 30 min of acupuncture-moxibustion therapy 3 times weekly during the first 4 weeks and twice a week in the last 2 weeks, totally for 6 weeks. Before treatment, after treatment, in week 10, 18 and 30 of follow-up visits, the reflective total nasal symptom score (rTNSS), the total non-nasal symptom score (TNNSS), the total ophthalmic symptom score (TOSS), and the score of the rhinitis quality of life (RQLQ) scale were compared in the patients of the two groups separately. Using ELISA, the serum concentrations of total immunoglobulin E (IgE) and interleukin-4 (IL-4) were detected before and after treatment. Results: After treatment, the rTNSS, TNNSS, TOSS, as well as RQLQ score were lower in comparison with those before treatment in each group ( P <0.05).The rTNSS, TNNSS, TOSS and the score of RQLQ in the week 10, 18 and 30 of follow-up visits were reduced when compared with those before treatment in each group ( P <0.05), and these scores in the acupuncture + western medicine group were remarkably lower than those of the western medicine group ( P <0.05). After treatment, the serum contents of total IgE and IL-4 were significantly decreased when compared with those before treatment in the acupuncture + western medicine group ( P <0.05), and these indicators in the acupuncture + western medicine group were lower than those of the western medicine group ( P <0.05). Conclusion: On the base of treatment with fluticasone propionate nasal spray, "Fuyang Guben" acupuncture-moxibustion therapy is safe and effective on PAR, presenting a remarkably long-term efficacy. The functioning mechanism may be related to the down-regulation of total IgE and IL-4 in serum.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu